The anti-IgE antibody omalizumab reduces exacerbations and steroid requirement in allergic asthmaticsM. Solèr, Giovanni Della Cioppa|European Respiratory Journal|2001Cited by 826
Efficacy and safety of a recombinant anti‐immunoglobulin E antibody (omalizumab) in severe allergic asthmaStephen T. Holgate, Jan Lötvall, Gert Persson et al.|Clinical & Experimental Allergy|2004Cited by 520